期刊文献+

罗氏Cobas c501检测系统尿素分析测量范围的验证及评价 被引量:2

Evaluation and Validation of Analytical Measurement Range of Urea Detected by Roche Cobas c501 Full-Automatic Biochemistry Assay System
下载PDF
导出
摘要 目的:核实并评价罗氏Cobasc501检测系统尿素分析测量范围。方法:主要参照美国临床实验室标准化委员会(NCCLS)指南文件EP6-P的要求,收集含高值待测物的新鲜病人血清,按一定比例混合、离心,计算混合物的浓度并将之作为高值样品(H),与经同样处理获得的低值样品(L)分别按5L、4L+1H、3L+2H、2L+3H、1L+4H、5H的关系配制,形成系列样品,在罗氏Cobasc501检测系统上对各样品的尿素进行检测,每个样品检测4次,数据进行回归分析。结果:回归方程为y=0.9889x+0.19,b=0.9889,介于0.97~1.03之间,ta小于t0.05,说明截距与0无显著性差异,回归直线事实上通过零点。结论:罗氏Cobasc501检测系统检测尿素的分析测量范围为0.7~49.9mmol/L,宽于厂家提供的分析测量范围0.5~40.0mmol/L,完全符合临床检验要求。 Objective: To evaluate and validate analytical measurement range of urea detected by Roche Cobas c501 full-automatic biochemistry assay system. Methods: Referring to NCCLS EP6-P evaluation protocols mainly. First, fresh sera from patient were collected and mixed to formed the high(H) and low(L) urea concentration sample respectively. Second, serial sera were produced according to the relation of 5L, 4L+1H, 3L+2H, 2L+3H, 1L+ 4H, 5H. Last, Urea of each sample were detected four times by Roche Cobas c501 full-automatic biochemistry assay system, and data were obtained and analyzed. Results: Regression equation of y=0.9889x+0.19 is deduced, and the b value(0.9889) is between 0.97~1.03. compared a to 0, tat0.05, which shows standard curve is through zero in fact. Conclusion: Analytical measurement range of urea detected by Roche Cobas c501 full-automatic biochemistry assay system is actually 0.7~49.9 mmol / L and wider than analytical measurement range 0.5~40.0 mmol / L afforded by manufactory.
出处 《生物技术通讯》 CAS 2010年第4期568-570,共3页 Letters in Biotechnology
关键词 检测系统 尿素 分析测量范围 验证 assay system urea analytical measurement range validation
  • 相关文献

参考文献4

  • 1扬振华,王治国.临床实验室质量管理[M].北京:人民卫生出版社,2003:157-159.
  • 2Department of Health,Human Services,Centers for Medicare & Medicaid Services.Clinical laboratory improvement amendments of 1988:final rule[Z].Fed Register,2003:3704-3710.
  • 3毕波,吕元.定量检测方法学性能验证的系统设计[J].中华检验医学杂志,2007,30(2):143-145. 被引量:153
  • 4NCCLS.EP6-P2,Evaluation of the linearity of quantative analyticalmethods[Z].Proposed guideline(second edition),2002:1-55.

二级参考文献6

  • 1Department of Health and Human Services,Centers for Medicare & Medicaid Services.Clinical laboratory improvement amendments of 1988:final rule.Fed Register,2003:3704.
  • 2NCCLS.EP10-A Preliminary evaluation of quantitative clinical laboratory methods.Wayne PA:National Committee for Clinical Laboratory Standards,1998.
  • 3Spencer CA.Thyroid profiling for the 1990s:free T4 estimate or sensitive TSH measurement.J Clin Immunoassay,1989,12:82-89.
  • 4NCCLS.EP6-P2 Evaluation of linearity of quantitative analytical methods.Proposed guideline-second edition,2002.21-20.
  • 5NCCLS.C28-A2 How to define and determine reference intervals in the clinical laboratory; approved guideline.Wayne PA:NCCLS,2000.
  • 6NCCLS.EP9-A Method comparison and bias estimation using patient samples.Wayne PA:National Committee for Clinical Laboratory Standards,1995.

共引文献154

同被引文献11

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部